VTUS Insider Trading Activity and SEC Form 4 Filings
VTUS insider trading summary
No open-market insider purchases or sales of Ventrus Biosciences Inc (VTUS) have been reported on SEC Form 4 in the past 12 months.
Latest VTUS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 27, 2014 | Russell H Ellison | Chief Executive Officer | Buy | $12K (13,000 @ $0.92) |
| May 23, 2014 | David Jonathan Barrett | Chief Financial Officer | Buy | $880 (1,000 @ $0.88) |
| May 23, 2014 | Russell H Ellison | Chief Executive Officer | Buy | $14K (15,000 @ $0.91) |
| May 22, 2014 | David Jonathan Barrett | Chief Financial Officer | Buy | $5K (5,980 @ $0.86) |
| May 22, 2014 | Russell H Ellison | Chief Executive Officer | Buy | $5K (5,000 @ $0.90) |
| May 21, 2014 | Russell H Ellison | Chief Executive Officer | Buy | $9K (10,000 @ $0.87) |
| May 20, 2014 | David Jonathan Barrett | Chief Financial Officer | Buy | $35K (40,000 @ $0.88) |
| Feb 5, 2013 | Russell H Ellison | Chief Executive Officer | Buy | $15K (5,624 @ $2.59) |
| Feb 4, 2013 | Russell H Ellison | Chief Executive Officer | Buy | $24K (9,376 @ $2.52) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.